Patient Attitudes Toward Blood‐Based Biomarker Testing for Alzheimer's Disease in Primary Care: Anticipated Results from the BLOOM‐AD Study
The BLOOM-AD study will deepen our understanding of patient perspectives on BBMs in primary care, with a focus on diverse populations. These insights will inform strategies to improve outreach, address disparities, and promote early AD detection and prevention, ensuring equitable access and addressing patient concerns in clinical practice.
Authors
- Adam M. Brickman (ORCID: https://orcid.org/0000-0002-5125-8226)
- R. A. Bell
- Stephanie Batio
- Suzanne Craft (ORCID: https://orcid.org/0000-0003-0591-8657)
- Andrea M. Russell (ORCID: https://orcid.org/0000-0001-6869-9581)
- Chinedu Udeh‐Momoh (ORCID: https://orcid.org/0000-0002-7357-4692)
- Morgan Bonham
- Laura D. Baker (ORCID: https://orcid.org/0000-0002-6217-7384)
- Marlene Wolf (ORCID: https://orcid.org/0000-0002-7283-4683)
- Joseph M. Curran
- Rebecca Lovett (ORCID: https://orcid.org/0000-0003-0169-9485)
- Michelle M. Mielke (ORCID: https://orcid.org/0000-0001-7177-1185)
- Selina Quinones (ORCID: https://orcid.org/0009-0006-7142-6676)
- Jeimmy Hurtado
- JD Williamson
- Wei Huang
- Goldie S Byrd
Institutions
- Northwestern University (US)
- Aga Khan University Nairobi (KE)
- Wake Forest University (US)
- Columbia University (US)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1002/alz70860_103795
- Primary Topic
- Dementia and Cognitive Impairment Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00